Long COVID 101: Patients and Doctors Explain the Condition
Decades after the 1918 flu pandemic, epidemiologists discovered that survivors were up to three times as likely to develop Parkinson’s disease. This wasn’t a…
Decades after the 1918 flu pandemic, epidemiologists discovered that survivors were up to three times as likely to develop Parkinson’s disease. This wasn’t a…
Women were historically excluded from medical research. The move was originally intended to keep them safe — but in a way, it did the…
Editor’s note: This is a mouse study. Studies in mice rarely translate to humans. An inert and unreactive gas may not seem like an…
Whether it’s mild cognitive impairment or an advanced stage of Alzheimer’s, a diagnosis of cognitive decline is life-changing. It can also be motivating —…
When the COVID-19 pandemic hit in 2019, researchers raised concerns it would increase the risk of neurodegenerative diseases like Alzheimer’s and Parkinson’s. A recent…
There’s a hereditary typo in Doug Whitney’s genetic code: a variant that all but guarantees its carriers will contract Alzheimer’s disease within their lifetime….
From clinical trials to funding cuts: Here’s how changes at NIH are reshaping Alzheimer’s and dementia research. As of September 2024, 495 clinical trials…
One morning, Lori noticed her husband, Bob, couldn’t form a sentence — he was having a stroke. He was diagnosed with MCI due to…
Want to prevent dementia? Here are a few healthy, low-risk, science-backed approaches to lowering your risk. Dementia has no cure. And while there is…
Infectious or chronic diseases such as long COVID, Alzheimer’s disease and traumatic brain injury can cause inflammation in the brain, or neuroinflammation, that weakens…
Long COVID, a baffling constellation of physical symptoms that may persist long after a bout of COVID-19, can strike almost every system in the…
For many people, correcting loved ones comes from a place of care and a desire to help others grow intellectually. However, conversations with a…
When retired interior designer Denis Lowe began to have problems with multitasking and presenting designs to clients, he knew something was wrong. Three years…
Eisai and Biogen’s Alzheimer’s drug Leqembi (generic name lecanemab) was the first fully-FDA approved disease-modifying treatment for early-stage Alzheimer’s disease in United States history,…
Can a seemingly harmless virus in the gut wreak havoc on the brain decades after the initial infection? And could catching and treating an…